Titre : Mécanismes moléculaires de l'action pharmacologique

Mécanismes moléculaires de l'action pharmacologique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Nucleosides

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment identifier un mécanisme d'action d'un médicament ?

L'analyse des interactions moléculaires et des voies de signalisation aide à identifier les mécanismes.
Mécanismes d'action Pharmacologie
#2

Quels tests sont utilisés pour étudier les mécanismes moléculaires ?

Des tests in vitro, des études de liaison et des analyses génétiques sont couramment utilisés.
Tests in vitro Analyse génétique
#3

Quelles techniques d'imagerie aident au diagnostic ?

L'imagerie par résonance magnétique et la tomographie permettent d'observer les effets des médicaments.
Imagerie médicale Tomographie
#4

Comment les biomarqueurs sont-ils utilisés dans le diagnostic ?

Les biomarqueurs aident à évaluer l'efficacité et la sécurité des médicaments en fonction de leur mécanisme.
Biomarqueurs Pharmacogénomique
#5

Quel rôle joue la pharmacogénomique dans le diagnostic ?

Elle permet d'adapter les traitements en fonction des variations génétiques influençant les mécanismes d'action.
Pharmacogénomique Génétique

Symptômes 5

#1

Quels symptômes indiquent un effet pharmacologique ?

Les symptômes peuvent inclure des changements physiologiques, des effets secondaires ou des améliorations cliniques.
Effets secondaires Symptômes
#2

Comment les effets indésirables sont-ils liés aux mécanismes d'action ?

Les effets indésirables résultent souvent d'interactions non spécifiques avec des cibles moléculaires.
Effets indésirables Interactions médicamenteuses
#3

Quels symptômes sont associés aux médicaments ciblant les récepteurs ?

Les symptômes peuvent inclure des modifications de la perception, de l'humeur ou de la douleur.
Récepteurs Symptômes
#4

Comment les symptômes varient-ils selon les mécanismes d'action ?

Les symptômes varient en fonction des cibles moléculaires et des voies de signalisation affectées.
Voies de signalisation Pharmacologie
#5

Quels symptômes peuvent indiquer une surdose ?

Des symptômes tels que des nausées, des vertiges ou des troubles de la conscience peuvent indiquer une surdose.
Surdose Symptômes

Prévention 5

#1

Comment prévenir les effets indésirables des médicaments ?

Une évaluation des mécanismes d'action et des interactions médicamenteuses peut aider à prévenir les effets indésirables.
Prévention Effets indésirables
#2

Quel rôle joue l'éducation des patients dans la prévention ?

L'éducation des patients sur les mécanismes d'action des médicaments peut améliorer l'adhésion et réduire les risques.
Éducation des patients Adhésion au traitement
#3

Comment les études cliniques aident-elles à prévenir les complications ?

Les études cliniques identifient les mécanismes d'action et les effets indésirables potentiels, permettant une meilleure prévention.
Études cliniques Complications
#4

Quels facteurs influencent la prévention des effets indésirables ?

Les facteurs incluent la génétique, l'âge, les comorbidités et les interactions médicamenteuses.
Facteurs de risque Interactions médicamenteuses
#5

Comment les recommandations de traitement aident-elles à prévenir les risques ?

Les recommandations basées sur les mécanismes d'action aident à choisir des traitements plus sûrs et efficaces.
Recommandations de traitement Sécurité des médicaments

Traitements 5

#1

Comment les médicaments ciblent-ils des mécanismes spécifiques ?

Les médicaments sont conçus pour interagir avec des cibles moléculaires spécifiques, comme des enzymes ou des récepteurs.
Cibles moléculaires Médicaments
#2

Quels traitements utilisent des mécanismes d'action innovants ?

Les thérapies géniques et les médicaments biologiques exploitent des mécanismes d'action novateurs.
Thérapie génique Médicaments biologiques
#3

Comment les traitements sont-ils personnalisés ?

Les traitements sont adaptés en fonction des caractéristiques moléculaires des patients et des médicaments.
Médecine personnalisée Pharmacogénomique
#4

Quel est l'impact des mécanismes d'action sur l'efficacité des traitements ?

Une compréhension approfondie des mécanismes d'action permet d'optimiser l'efficacité et de réduire les effets secondaires.
Efficacité Mécanismes d'action
#5

Comment les combinaisons de médicaments exploitent les mécanismes d'action ?

Les combinaisons de médicaments peuvent cibler plusieurs mécanismes pour améliorer l'efficacité thérapeutique.
Thérapies combinées Mécanismes d'action

Complications 5

#1

Quelles complications peuvent survenir avec des médicaments ?

Les complications peuvent inclure des réactions allergiques, des effets toxiques ou des interactions médicamenteuses.
Complications Réactions allergiques
#2

Comment les mécanismes d'action influencent-ils les complications ?

Les mécanismes d'action peuvent déterminer la sévérité et la nature des complications observées.
Mécanismes d'action Sévérité des complications
#3

Quels sont les signes de complications graves ?

Des signes tels que des difficultés respiratoires, des éruptions cutanées ou des douleurs thoraciques peuvent indiquer des complications graves.
Signes cliniques Complications graves
#4

Comment gérer les complications liées aux médicaments ?

La gestion des complications implique l'arrêt du médicament, le traitement des symptômes et la surveillance étroite.
Gestion des complications Surveillance médicale
#5

Quel rôle joue la pharmacovigilance dans la détection des complications ?

La pharmacovigilance surveille les effets indésirables et les complications pour améliorer la sécurité des médicaments.
Pharmacovigilance Sécurité des médicaments

Facteurs de risque 5

#1

Quels facteurs de risque influencent l'efficacité des médicaments ?

Les facteurs incluent l'âge, le sexe, la génétique et les comorbidités qui peuvent affecter l'efficacité.
Facteurs de risque Efficacité des médicaments
#2

Comment les interactions médicamenteuses sont-elles un facteur de risque ?

Les interactions médicamenteuses peuvent altérer les mécanismes d'action et augmenter le risque d'effets indésirables.
Interactions médicamenteuses Effets indésirables
#3

Quel impact a l'alimentation sur les mécanismes d'action ?

L'alimentation peut influencer l'absorption et le métabolisme des médicaments, affectant leur efficacité.
Alimentation Métabolisme des médicaments
#4

Comment le mode de vie affecte-t-il les traitements ?

Le mode de vie, y compris l'exercice et le tabagisme, peut modifier la réponse aux médicaments et leurs mécanismes d'action.
Mode de vie Réponse au traitement
#5

Quels facteurs environnementaux influencent les effets des médicaments ?

Les facteurs environnementaux, comme la pollution, peuvent interagir avec les mécanismes d'action des médicaments.
Facteurs environnementaux Pollution
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mécanismes moléculaires de l'action pharmacologique : Questions médicales les plus fréquentes", "headline": "Mécanismes moléculaires de l'action pharmacologique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mécanismes moléculaires de l'action pharmacologique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-16", "dateModified": "2025-02-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mécanismes moléculaires de l'action pharmacologique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Actions pharmacologiques", "url": "https://questionsmedicales.fr/mesh/D020228", "about": { "@type": "MedicalCondition", "name": "Actions pharmacologiques", "code": { "@type": "MedicalCode", "code": "D020228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs aux angiotensines", "alternateName": "Angiotensin Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D057911", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs aux angiotensines", "code": { "@type": "MedicalCode", "code": "D057911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.162" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type 1 de l'angiotensine-II", "alternateName": "Angiotensin II Type 1 Receptor Blockers", "url": "https://questionsmedicales.fr/mesh/D047228", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type 1 de l'angiotensine-II", "code": { "@type": "MedicalCode", "code": "D047228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.162.500" } } }, { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type 2 de l'angiotensine-II", "alternateName": "Angiotensin II Type 2 Receptor Blockers", "url": "https://questionsmedicales.fr/mesh/D057912", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type 2 de l'angiotensine-II", "code": { "@type": "MedicalCode", "code": "D057912", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.162.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Agents antiglycation", "alternateName": "Antiglycation Agents", "url": "https://questionsmedicales.fr/mesh/D000093744", "about": { "@type": "MedicalCondition", "name": "Agents antiglycation", "code": { "@type": "MedicalCode", "code": "D000093744", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.182" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la synthèse d'acides gras", "alternateName": "Fatty Acid Synthesis Inhibitors", "url": "https://questionsmedicales.fr/mesh/D054872", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la synthèse d'acides gras", "code": { "@type": "MedicalCode", "code": "D054872", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.186.071.401" } } }, { "@type": "MedicalWebPage", "name": "Piégeurs de radicaux libres", "alternateName": "Free Radical Scavengers", "url": "https://questionsmedicales.fr/mesh/D016166", "about": { "@type": "MedicalCondition", "name": "Piégeurs de radicaux libres", "code": { "@type": "MedicalCode", "code": "D016166", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.217.500" } } }, { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs de la bradykinine", "alternateName": "Bradykinin Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065168", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs de la bradykinine", "code": { "@type": "MedicalCode", "code": "D065168", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.265" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur B1 de la bradykinine", "alternateName": "Bradykinin B1 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065169", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur B1 de la bradykinine", "code": { "@type": "MedicalCode", "code": "D065169", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.265.249" } } } ] }, { "@type": "MedicalWebPage", "name": "Agents de déplétion en cystine", "alternateName": "Cystine Depleting Agents", "url": "https://questionsmedicales.fr/mesh/D065104", "about": { "@type": "MedicalCondition", "name": "Agents de déplétion en cystine", "code": { "@type": "MedicalCode", "code": "D065104", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.334" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs des enzymes du cytochrome P-450", "alternateName": "Cytochrome P-450 Enzyme Inducers", "url": "https://questionsmedicales.fr/mesh/D065693", "about": { "@type": "MedicalCondition", "name": "Inducteurs des enzymes du cytochrome P-450", "code": { "@type": "MedicalCode", "code": "D065693", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP1A2", "alternateName": "Cytochrome P-450 CYP1A2 Inducers", "url": "https://questionsmedicales.fr/mesh/D065694", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP1A2", "code": { "@type": "MedicalCode", "code": "D065694", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.120" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2B6", "alternateName": "Cytochrome P-450 CYP2B6 Inducers", "url": "https://questionsmedicales.fr/mesh/D065695", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2B6", "code": { "@type": "MedicalCode", "code": "D065695", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.260" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2C8", "alternateName": "Cytochrome P-450 CYP2C8 Inducers", "url": "https://questionsmedicales.fr/mesh/D065696", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2C8", "code": { "@type": "MedicalCode", "code": "D065696", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.308" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2C9", "alternateName": "Cytochrome P-450 CYP2C9 Inducers", "url": "https://questionsmedicales.fr/mesh/D065698", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2C9", "code": { "@type": "MedicalCode", "code": "D065698", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.320" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2C19", "alternateName": "Cytochrome P-450 CYP2C19 Inducers", "url": "https://questionsmedicales.fr/mesh/D065697", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2C19", "code": { "@type": "MedicalCode", "code": "D065697", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.350" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2D6", "alternateName": "Cytochrome P-450 CYP2D6 Inducers", "url": "https://questionsmedicales.fr/mesh/D065699", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2D6", "code": { "@type": "MedicalCode", "code": "D065699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.500" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2E1", "alternateName": "Cytochrome P-450 CYP2E1 Inducers", "url": "https://questionsmedicales.fr/mesh/D065700", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2E1", "code": { "@type": "MedicalCode", "code": "D065700", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.600" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP3A", "alternateName": "Cytochrome P-450 CYP3A Inducers", "url": "https://questionsmedicales.fr/mesh/D065701", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP3A", "code": { "@type": "MedicalCode", "code": "D065701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs de l'endothéline", "alternateName": "Endothelin Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065128", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs de l'endothéline", "code": { "@type": "MedicalCode", "code": "D065128", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.364" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type A de l'endothéline", "alternateName": "Endothelin A Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065130", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type A de l'endothéline", "code": { "@type": "MedicalCode", "code": "D065130", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.364.500" } } }, { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type B de l'endothéline", "alternateName": "Endothelin B Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065131", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type B de l'endothéline", "code": { "@type": "MedicalCode", "code": "D065131", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.364.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Activateurs d'enzymes", "alternateName": "Enzyme Activators", "url": "https://questionsmedicales.fr/mesh/D020536", "about": { "@type": "MedicalCondition", "name": "Activateurs d'enzymes", "code": { "@type": "MedicalCode", "code": "D020536", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.374" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Activateurs de la Carbamoyl phosphate synthetase I", "alternateName": "Carbamoyl Phosphate Synthetase I Activators", "url": "https://questionsmedicales.fr/mesh/D065097", "about": { "@type": "MedicalCondition", "name": "Activateurs de la Carbamoyl phosphate synthetase I", "code": { "@type": "MedicalCode", "code": "D065097", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.374.099" } } }, { "@type": "MedicalWebPage", "name": "Activateurs de la GTPase", "alternateName": "GTP Phosphohydrolase Activators", "url": "https://questionsmedicales.fr/mesh/D020549", "about": { "@type": "MedicalCondition", "name": "Activateurs de la GTPase", "code": { "@type": "MedicalCode", "code": "D020549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.374.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Antienzymes", "alternateName": "Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D004791", "about": { "@type": "MedicalCondition", "name": "Antienzymes", "code": { "@type": "MedicalCode", "code": "D004791", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des protéines activatrices de la 5-lipoxygénase", "alternateName": "5-Lipoxygenase-Activating Protein Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058946", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des protéines activatrices de la 5-lipoxygénase", "code": { "@type": "MedicalCode", "code": "D058946", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.086" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'acétaldéhyde déshydrogénase", "alternateName": "Acetaldehyde Dehydrogenase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065086", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'acétaldéhyde déshydrogénase", "code": { "@type": "MedicalCode", "code": "D065086", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.089" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'adénosine désaminase", "alternateName": "Adenosine Deaminase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058892", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'adénosine désaminase", "code": { "@type": "MedicalCode", "code": "D058892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.092" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des adénylate cyclases", "alternateName": "Adenylyl Cyclase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000067956", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des adénylate cyclases", "code": { "@type": "MedicalCode", "code": "D000067956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.108" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la calcineurine", "alternateName": "Calcineurin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065095", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la calcineurine", "code": { "@type": "MedicalCode", "code": "D065095", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.174" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'anhydrase carbonique", "alternateName": "Carbonic Anhydrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D002257", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'anhydrase carbonique", "code": { "@type": "MedicalCode", "code": "D002257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.200" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs et modulateurs de la gamma-secrétase", "alternateName": "Gamma Secretase Inhibitors and Modulators", "url": "https://questionsmedicales.fr/mesh/D000091062", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs et modulateurs de la gamma-secrétase", "code": { "@type": "MedicalCode", "code": "D000091062", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.315" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des enzymes du cytochrome P-450", "alternateName": "Cytochrome P-450 Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065607", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des enzymes du cytochrome P-450", "code": { "@type": "MedicalCode", "code": "D065607", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "alternateName": "Cytochrome P-450 CYP1A2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065609", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "code": { "@type": "MedicalCode", "code": "D065609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.120" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "alternateName": "Cytochrome P-450 CYP2B6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065686", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "code": { "@type": "MedicalCode", "code": "D065686", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.260" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "alternateName": "Cytochrome P-450 CYP2C8 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065687", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "code": { "@type": "MedicalCode", "code": "D065687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.308" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "alternateName": "Cytochrome P-450 CYP2C19 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065689", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "code": { "@type": "MedicalCode", "code": "D065689", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.319" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "alternateName": "Cytochrome P-450 CYP2C9 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065688", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "code": { "@type": "MedicalCode", "code": "D065688", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.329" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "alternateName": "Cytochrome P-450 CYP2D6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065690", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "code": { "@type": "MedicalCode", "code": "D065690", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.368" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "alternateName": "Cytochrome P-450 CYP2E1 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065691", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "code": { "@type": "MedicalCode", "code": "D065691", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.421" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "alternateName": "Cytochrome P-450 CYP3A Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065692", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "code": { "@type": "MedicalCode", "code": "D065692", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.503" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "alternateName": "Cytochrome P-450 CYP1A2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065609", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "code": { "@type": "MedicalCode", "code": "D065609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.120" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "alternateName": "Cytochrome P-450 CYP2B6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065686", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "code": { "@type": "MedicalCode", "code": "D065686", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.260" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "alternateName": "Cytochrome P-450 CYP2C8 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065687", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "code": { "@type": "MedicalCode", "code": "D065687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.308" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "alternateName": "Cytochrome P-450 CYP2C19 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065689", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "code": { "@type": "MedicalCode", "code": "D065689", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.319" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "alternateName": "Cytochrome P-450 CYP2C9 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065688", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "code": { "@type": "MedicalCode", "code": "D065688", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.329" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "alternateName": "Cytochrome P-450 CYP2D6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065690", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "code": { "@type": "MedicalCode", "code": "D065690", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.368" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "alternateName": "Cytochrome P-450 CYP2E1 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065691", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "code": { "@type": "MedicalCode", "code": "D065691", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.421" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "alternateName": "Cytochrome P-450 CYP3A Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065692", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "code": { "@type": "MedicalCode", "code": "D065692", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.503" } } }, { "@type": "MedicalWebPage", "name": "Antifoliques", "alternateName": "Folic Acid Antagonists", "url": "https://questionsmedicales.fr/mesh/D005493", "about": { "@type": "MedicalCondition", "name": "Antifoliques", "code": { "@type": "MedicalCode", "code": "D005493", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.350" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de désacétylase d'histone", "alternateName": "Histone Deacetylase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D056572", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de désacétylase d'histone", "code": { "@type": "MedicalCode", "code": "D056572", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.360" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'intégrase", "alternateName": "Integrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019429", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'intégrase", "code": { "@type": "MedicalCode", "code": "D019429", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.375" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la lipoxygénase", "alternateName": "Lipoxygenase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D016859", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la lipoxygénase", "code": { "@type": "MedicalCode", "code": "D016859", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.480" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la monoamine oxydase", "alternateName": "Monoamine Oxidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D008996", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la monoamine oxydase", "code": { "@type": "MedicalCode", "code": "D008996", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.616" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la synthèse d'acide nucléique", "alternateName": "Nucleic Acid Synthesis Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019384", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la synthèse d'acide nucléique", "code": { "@type": "MedicalCode", "code": "D019384", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'ornithine décarboxylase", "alternateName": "Ornithine Decarboxylase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065108", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'ornithine décarboxylase", "code": { "@type": "MedicalCode", "code": "D065108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.705" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase", "alternateName": "Phosphodiesterase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D010726", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase", "code": { "@type": "MedicalCode", "code": "D010726", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-3", "alternateName": "Phosphodiesterase 3 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058987", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-3", "code": { "@type": "MedicalCode", "code": "D058987", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.249" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-4", "alternateName": "Phosphodiesterase 4 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-4", "code": { "@type": "MedicalCode", "code": "D058988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.374" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-5", "alternateName": "Phosphodiesterase 5 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058986", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-5", "code": { "@type": "MedicalCode", "code": "D058986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-3", "alternateName": "Phosphodiesterase 3 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058987", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-3", "code": { "@type": "MedicalCode", "code": "D058987", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.249" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-4", "alternateName": "Phosphodiesterase 4 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-4", "code": { "@type": "MedicalCode", "code": "D058988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.374" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-5", "alternateName": "Phosphodiesterase 5 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058986", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-5", "code": { "@type": "MedicalCode", "code": "D058986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des phosphoinositide-3 kinases", "alternateName": "Phosphoinositide-3 Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000081082", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des phosphoinositide-3 kinases", "code": { "@type": "MedicalCode", "code": "D000081082", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.736" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phospholipase A2", "alternateName": "Phospholipase A2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D064801", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phospholipase A2", "code": { "@type": "MedicalCode", "code": "D064801", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.737" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de prolyle hydroxylases", "alternateName": "Prolyl-Hydroxylase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D064800", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de prolyle hydroxylases", "code": { "@type": "MedicalCode", "code": "D064800", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.740" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéases", "alternateName": "Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D011480", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéases", "code": { "@type": "MedicalCode", "code": "D011480", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "alternateName": "Angiotensin-Converting Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000806", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "code": { "@type": "MedicalCode", "code": "D000806", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la cystéine protéinase", "alternateName": "Cysteine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015853", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la cystéine protéinase", "code": { "@type": "MedicalCode", "code": "D015853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de métalloprotéinases matricielles", "alternateName": "Matrix Metalloproteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061965", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de métalloprotéinases matricielles", "code": { "@type": "MedicalCode", "code": "D061965", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.610" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du protéasome", "alternateName": "Proteasome Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du protéasome", "code": { "@type": "MedicalCode", "code": "D061988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.705" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la rénine", "alternateName": "Renin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092502", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la rénine", "code": { "@type": "MedicalCode", "code": "D000092502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.753" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la sérine protéinase", "alternateName": "Serine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015842", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la sérine protéinase", "code": { "@type": "MedicalCode", "code": "D015842", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "alternateName": "Angiotensin-Converting Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000806", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "code": { "@type": "MedicalCode", "code": "D000806", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la cystéine protéinase", "alternateName": "Cysteine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015853", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la cystéine protéinase", "code": { "@type": "MedicalCode", "code": "D015853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de métalloprotéinases matricielles", "alternateName": "Matrix Metalloproteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061965", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de métalloprotéinases matricielles", "code": { "@type": "MedicalCode", "code": "D061965", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.610" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du protéasome", "alternateName": "Proteasome Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du protéasome", "code": { "@type": "MedicalCode", "code": "D061988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.705" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la rénine", "alternateName": "Renin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092502", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la rénine", "code": { "@type": "MedicalCode", "code": "D000092502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.753" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la sérine protéinase", "alternateName": "Serine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015842", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la sérine protéinase", "code": { "@type": "MedicalCode", "code": "D015842", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéines kinases", "alternateName": "Protein Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D047428", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéines kinases", "code": { "@type": "MedicalCode", "code": "D047428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des Janus kinases", "alternateName": "Janus Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075242", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des Janus kinases", "code": { "@type": "MedicalCode", "code": "D000075242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéine-tyrosine kinase", "alternateName": "Tyrosine Protein Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092004", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéine-tyrosine kinase", "code": { "@type": "MedicalCode", "code": "D000092004", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des Janus kinases", "alternateName": "Janus Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075242", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des Janus kinases", "code": { "@type": "MedicalCode", "code": "D000075242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéine-tyrosine kinase", "alternateName": "Tyrosine Protein Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092004", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéine-tyrosine kinase", "code": { "@type": "MedicalCode", "code": "D000092004", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.875" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la synthèse protéique", "alternateName": "Protein Synthesis Inhibitors", "url": "https://questionsmedicales.fr/mesh/D011500", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la synthèse protéique", "code": { "@type": "MedicalCode", "code": "D011500", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.760" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la pompe à protons", "alternateName": "Proton Pump Inhibitors", "url": "https://questionsmedicales.fr/mesh/D054328", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la pompe à protons", "code": { "@type": "MedicalCode", "code": "D054328", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.848" } } }, { "@type": "MedicalWebPage", "name": "Agents découplants", "alternateName": "Uncoupling Agents", "url": "https://questionsmedicales.fr/mesh/D014475", "about": { "@type": "MedicalCondition", "name": "Agents découplants", "code": { "@type": "MedicalCode", "code": "D014475", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.936" } } } ] }, { "@type": "MedicalWebPage", "name": "Réactivateurs d'enzymes", "alternateName": "Enzyme Reactivators", "url": "https://questionsmedicales.fr/mesh/D004793", "about": { "@type": "MedicalCondition", "name": "Réactivateurs d'enzymes", "code": { "@type": "MedicalCode", "code": "D004793", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.405" } } }, { "@type": "MedicalWebPage", "name": "Modulateurs de la fibrinolyse", "alternateName": "Fibrin Modulating Agents", "url": "https://questionsmedicales.fr/mesh/D050299", "about": { "@type": "MedicalCondition", "name": "Modulateurs de la fibrinolyse", "code": { "@type": "MedicalCode", "code": "D050299", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.421" } } }, { "@type": "MedicalWebPage", "name": "Modulateurs du transport transmembranaire", "alternateName": "Membrane Transport Modulators", "url": "https://questionsmedicales.fr/mesh/D049990", "about": { "@type": "MedicalCondition", "name": "Modulateurs du transport transmembranaire", "code": { "@type": "MedicalCode", "code": "D049990", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agonistes de canaux chlorure", "alternateName": "Chloride Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D065101", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux chlorure", "code": { "@type": "MedicalCode", "code": "D065101", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.311" } } }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques", "alternateName": "Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D062687", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques", "code": { "@type": "MedicalCode", "code": "D062687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques épithéliaux", "alternateName": "Epithelial Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D062708", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques épithéliaux", "code": { "@type": "MedicalCode", "code": "D062708", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.249" } } }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques voltage-dépendants", "alternateName": "Voltage-Gated Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D061585", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques voltage-dépendants", "code": { "@type": "MedicalCode", "code": "D061585", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques épithéliaux", "alternateName": "Epithelial Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D062708", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques épithéliaux", "code": { "@type": "MedicalCode", "code": "D062708", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.249" } } }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques voltage-dépendants", "alternateName": "Voltage-Gated Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D061585", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques voltage-dépendants", "code": { "@type": "MedicalCode", "code": "D061585", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de canaux ioniques sensibles à l'acidité", "alternateName": "Acid Sensing Ion Channel Blockers", "url": "https://questionsmedicales.fr/mesh/D062646", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de canaux ioniques sensibles à l'acidité", "code": { "@type": "MedicalCode", "code": "D062646", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.750.100" } } } ] }, { "@type": "MedicalWebPage", "name": "Modulateurs de la mitose", "alternateName": "Mitosis Modulators", "url": "https://questionsmedicales.fr/mesh/D050258", "about": { "@type": "MedicalCondition", "name": "Modulateurs de la mitose", "code": { "@type": "MedicalCode", "code": "D050258", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.593" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Modulateurs de la polymérisation de la tubuline", "alternateName": "Tubulin Modulators", "url": "https://questionsmedicales.fr/mesh/D050257", "about": { "@type": "MedicalCondition", "name": "Modulateurs de la polymérisation de la tubuline", "code": { "@type": "MedicalCode", "code": "D050257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.593.249.500" } } }, { "@type": "MedicalWebPage", "name": "Mitogènes", "alternateName": "Mitogens", "url": "https://questionsmedicales.fr/mesh/D008934", "about": { "@type": "MedicalCondition", "name": "Mitogènes", "code": { "@type": "MedicalCode", "code": "D008934", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.593.624" } } } ] }, { "@type": "MedicalWebPage", "name": "Gazotransmetteurs", "alternateName": "Gasotransmitters", "url": "https://questionsmedicales.fr/mesh/D064426", "about": { "@type": "MedicalCondition", "name": "Gazotransmetteurs", "code": { "@type": "MedicalCode", "code": "D064426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.625.270" } } }, { "@type": "MedicalWebPage", "name": "Peptidomimétiques", "alternateName": "Peptidomimetics", "url": "https://questionsmedicales.fr/mesh/D057786", "about": { "@type": "MedicalCondition", "name": "Peptidomimétiques", "code": { "@type": "MedicalCode", "code": "D057786", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.828" } } } ], "about": { "@type": "MedicalCondition", "name": "Mécanismes moléculaires de l'action pharmacologique", "alternateName": "Molecular Mechanisms of Pharmacological Action", "code": { "@type": "MedicalCode", "code": "D045504", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Javad Sharifi-Rad", "url": "https://questionsmedicales.fr/author/Javad%20Sharifi-Rad", "affiliation": { "@type": "Organization", "name": "Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Daniela Calina", "url": "https://questionsmedicales.fr/author/Daniela%20Calina", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania." } }, { "@type": "Person", "name": "Yi Li", "url": "https://questionsmedicales.fr/author/Yi%20Li", "affiliation": { "@type": "Organization", "name": "The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China." } }, { "@type": "Person", "name": "Yan Wang", "url": "https://questionsmedicales.fr/author/Yan%20Wang", "affiliation": { "@type": "Organization", "name": "The Second Medical College, Binzhou Medical University, Yantai, Shandong, China." } }, { "@type": "Person", "name": "Ibrahim Jantan", "url": "https://questionsmedicales.fr/author/Ibrahim%20Jantan", "affiliation": { "@type": "Organization", "name": "Institute of Systems Biology, Universiti Kebangsaan Malaysia, Selangor, Malaysia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs.", "datePublished": "2023-01-09", "url": "https://questionsmedicales.fr/article/36630750", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.copbio.2022.102873" } }, { "@type": "ScholarlyArticle", "name": "Chemoselective Acylation of Nucleosides.", "datePublished": "2022-07-26", "url": "https://questionsmedicales.fr/article/35730928", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/chem.202201661" } }, { "@type": "ScholarlyArticle", "name": "Engineering a Bifunctional Fusion Purine/Pyrimidine Nucleoside Phosphorylase for the Production of Nucleoside Analogs.", "datePublished": "2024-09-23", "url": "https://questionsmedicales.fr/article/39334962", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/biom14091196" } }, { "@type": "ScholarlyArticle", "name": "Chemo-Enzymatic Generation of Highly Fluorescent Nucleoside Analogs Using Purine-Nucleoside Phosphorylase.", "datePublished": "2024-06-14", "url": "https://questionsmedicales.fr/article/38927104", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/biom14060701" } }, { "@type": "ScholarlyArticle", "name": "In-source fragmentation of nucleosides in electrospray ionization towards more sensitive and accurate nucleoside analysis.", "datePublished": "2023-03-27", "url": "https://questionsmedicales.fr/article/36883656", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d3an00047h" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Mécanismes moléculaires de l'action pharmacologique", "item": "https://questionsmedicales.fr/mesh/D045504" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mécanismes moléculaires de l'action pharmacologique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mécanismes moléculaires de l'action pharmacologique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mécanismes moléculaires de l'action pharmacologique", "description": "Comment identifier un mécanisme d'action d'un médicament ?\nQuels tests sont utilisés pour étudier les mécanismes moléculaires ?\nQuelles techniques d'imagerie aident au diagnostic ?\nComment les biomarqueurs sont-ils utilisés dans le diagnostic ?\nQuel rôle joue la pharmacogénomique dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045504?mesh_terms=Nucleosides#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mécanismes moléculaires de l'action pharmacologique", "description": "Quels symptômes indiquent un effet pharmacologique ?\nComment les effets indésirables sont-ils liés aux mécanismes d'action ?\nQuels symptômes sont associés aux médicaments ciblant les récepteurs ?\nComment les symptômes varient-ils selon les mécanismes d'action ?\nQuels symptômes peuvent indiquer une surdose ?", "url": "https://questionsmedicales.fr/mesh/D045504?mesh_terms=Nucleosides#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mécanismes moléculaires de l'action pharmacologique", "description": "Comment prévenir les effets indésirables des médicaments ?\nQuel rôle joue l'éducation des patients dans la prévention ?\nComment les études cliniques aident-elles à prévenir les complications ?\nQuels facteurs influencent la prévention des effets indésirables ?\nComment les recommandations de traitement aident-elles à prévenir les risques ?", "url": "https://questionsmedicales.fr/mesh/D045504?mesh_terms=Nucleosides#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mécanismes moléculaires de l'action pharmacologique", "description": "Comment les médicaments ciblent-ils des mécanismes spécifiques ?\nQuels traitements utilisent des mécanismes d'action innovants ?\nComment les traitements sont-ils personnalisés ?\nQuel est l'impact des mécanismes d'action sur l'efficacité des traitements ?\nComment les combinaisons de médicaments exploitent les mécanismes d'action ?", "url": "https://questionsmedicales.fr/mesh/D045504?mesh_terms=Nucleosides#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mécanismes moléculaires de l'action pharmacologique", "description": "Quelles complications peuvent survenir avec des médicaments ?\nComment les mécanismes d'action influencent-ils les complications ?\nQuels sont les signes de complications graves ?\nComment gérer les complications liées aux médicaments ?\nQuel rôle joue la pharmacovigilance dans la détection des complications ?", "url": "https://questionsmedicales.fr/mesh/D045504?mesh_terms=Nucleosides#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mécanismes moléculaires de l'action pharmacologique", "description": "Quels facteurs de risque influencent l'efficacité des médicaments ?\nComment les interactions médicamenteuses sont-elles un facteur de risque ?\nQuel impact a l'alimentation sur les mécanismes d'action ?\nComment le mode de vie affecte-t-il les traitements ?\nQuels facteurs environnementaux influencent les effets des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D045504?mesh_terms=Nucleosides#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un mécanisme d'action d'un médicament ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse des interactions moléculaires et des voies de signalisation aide à identifier les mécanismes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les mécanismes moléculaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests in vitro, des études de liaison et des analyses génétiques sont couramment utilisés." } }, { "@type": "Question", "name": "Quelles techniques d'imagerie aident au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie par résonance magnétique et la tomographie permettent d'observer les effets des médicaments." } }, { "@type": "Question", "name": "Comment les biomarqueurs sont-ils utilisés dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les biomarqueurs aident à évaluer l'efficacité et la sécurité des médicaments en fonction de leur mécanisme." } }, { "@type": "Question", "name": "Quel rôle joue la pharmacogénomique dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'adapter les traitements en fonction des variations génétiques influençant les mécanismes d'action." } }, { "@type": "Question", "name": "Quels symptômes indiquent un effet pharmacologique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des changements physiologiques, des effets secondaires ou des améliorations cliniques." } }, { "@type": "Question", "name": "Comment les effets indésirables sont-ils liés aux mécanismes d'action ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets indésirables résultent souvent d'interactions non spécifiques avec des cibles moléculaires." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux médicaments ciblant les récepteurs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des modifications de la perception, de l'humeur ou de la douleur." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon les mécanismes d'action ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient en fonction des cibles moléculaires et des voies de signalisation affectées." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une surdose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes tels que des nausées, des vertiges ou des troubles de la conscience peuvent indiquer une surdose." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables des médicaments ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation des mécanismes d'action et des interactions médicamenteuses peut aider à prévenir les effets indésirables." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation des patients dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation des patients sur les mécanismes d'action des médicaments peut améliorer l'adhésion et réduire les risques." } }, { "@type": "Question", "name": "Comment les études cliniques aident-elles à prévenir les complications ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les études cliniques identifient les mécanismes d'action et les effets indésirables potentiels, permettant une meilleure prévention." } }, { "@type": "Question", "name": "Quels facteurs influencent la prévention des effets indésirables ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la génétique, l'âge, les comorbidités et les interactions médicamenteuses." } }, { "@type": "Question", "name": "Comment les recommandations de traitement aident-elles à prévenir les risques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les recommandations basées sur les mécanismes d'action aident à choisir des traitements plus sûrs et efficaces." } }, { "@type": "Question", "name": "Comment les médicaments ciblent-ils des mécanismes spécifiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments sont conçus pour interagir avec des cibles moléculaires spécifiques, comme des enzymes ou des récepteurs." } }, { "@type": "Question", "name": "Quels traitements utilisent des mécanismes d'action innovants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies géniques et les médicaments biologiques exploitent des mécanismes d'action novateurs." } }, { "@type": "Question", "name": "Comment les traitements sont-ils personnalisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements sont adaptés en fonction des caractéristiques moléculaires des patients et des médicaments." } }, { "@type": "Question", "name": "Quel est l'impact des mécanismes d'action sur l'efficacité des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une compréhension approfondie des mécanismes d'action permet d'optimiser l'efficacité et de réduire les effets secondaires." } }, { "@type": "Question", "name": "Comment les combinaisons de médicaments exploitent les mécanismes d'action ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les combinaisons de médicaments peuvent cibler plusieurs mécanismes pour améliorer l'efficacité thérapeutique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des médicaments ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des réactions allergiques, des effets toxiques ou des interactions médicamenteuses." } }, { "@type": "Question", "name": "Comment les mécanismes d'action influencent-ils les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les mécanismes d'action peuvent déterminer la sévérité et la nature des complications observées." } }, { "@type": "Question", "name": "Quels sont les signes de complications graves ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des signes tels que des difficultés respiratoires, des éruptions cutanées ou des douleurs thoraciques peuvent indiquer des complications graves." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux médicaments ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications implique l'arrêt du médicament, le traitement des symptômes et la surveillance étroite." } }, { "@type": "Question", "name": "Quel rôle joue la pharmacovigilance dans la détection des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La pharmacovigilance surveille les effets indésirables et les complications pour améliorer la sécurité des médicaments." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent l'efficacité des médicaments ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe, la génétique et les comorbidités qui peuvent affecter l'efficacité." } }, { "@type": "Question", "name": "Comment les interactions médicamenteuses sont-elles un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les interactions médicamenteuses peuvent altérer les mécanismes d'action et augmenter le risque d'effets indésirables." } }, { "@type": "Question", "name": "Quel impact a l'alimentation sur les mécanismes d'action ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'alimentation peut influencer l'absorption et le métabolisme des médicaments, affectant leur efficacité." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les traitements ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le mode de vie, y compris l'exercice et le tabagisme, peut modifier la réponse aux médicaments et leurs mécanismes d'action." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent les effets des médicaments ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs environnementaux, comme la pollution, peuvent interagir avec les mécanismes d'action des médicaments." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 10/02/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

86 au total
└─

Antagonistes des récepteurs aux angiotensines

Angiotensin Receptor Antagonists D057911 - D27.505.519.162
└─

Agents antiglycation

Antiglycation Agents D000093744 - D27.505.519.182
└─

Antagonistes des récepteurs de la bradykinine

Bradykinin Receptor Antagonists D065168 - D27.505.519.265
└─

Agents de déplétion en cystine

Cystine Depleting Agents D065104 - D27.505.519.334
└─

Inducteurs des enzymes du cytochrome P-450

Cytochrome P-450 Enzyme Inducers D065693 - D27.505.519.349
└─

Antagonistes des récepteurs de l'endothéline

Endothelin Receptor Antagonists D065128 - D27.505.519.364
└─

Activateurs d'enzymes

Enzyme Activators D020536 - D27.505.519.374
└─

Antienzymes

Enzyme Inhibitors D004791 - D27.505.519.389
└─

Réactivateurs d'enzymes

Enzyme Reactivators D004793 - D27.505.519.405
└─

Modulateurs de la fibrinolyse

Fibrin Modulating Agents D050299 - D27.505.519.421
└─

Modulateurs du transport transmembranaire

Membrane Transport Modulators D049990 - D27.505.519.562
└─

Modulateurs de la mitose

Mitosis Modulators D050258 - D27.505.519.593
└─

Peptidomimétiques

Peptidomimetics D057786 - D27.505.519.828
└─└─

Antagonistes du récepteur de type 1 de l'angiotensine-II

Angiotensin II Type 1 Receptor Blockers D047228 - D27.505.519.162.500
└─└─

Antagonistes du récepteur de type 2 de l'angiotensine-II

Angiotensin II Type 2 Receptor Blockers D057912 - D27.505.519.162.750
└─└─

Piégeurs de radicaux libres

Free Radical Scavengers D016166 - D27.505.519.217.500
└─└─

Antagonistes du récepteur B1 de la bradykinine

Bradykinin B1 Receptor Antagonists D065169 - D27.505.519.265.249
└─└─

Inducteurs du cytochrome P-450 CYP1A2

Cytochrome P-450 CYP1A2 Inducers D065694 - D27.505.519.349.120
└─└─

Inducteurs du cytochrome P-450 CYP2B6

Cytochrome P-450 CYP2B6 Inducers D065695 - D27.505.519.349.260
└─└─

Inducteurs du cytochrome P-450 CYP2C8

Cytochrome P-450 CYP2C8 Inducers D065696 - D27.505.519.349.308
└─└─

Inducteurs du cytochrome P-450 CYP2C9

Cytochrome P-450 CYP2C9 Inducers D065698 - D27.505.519.349.320
└─└─

Inducteurs du cytochrome P-450 CYP2C19

Cytochrome P-450 CYP2C19 Inducers D065697 - D27.505.519.349.350
└─└─

Inducteurs du cytochrome P-450 CYP2D6

Cytochrome P-450 CYP2D6 Inducers D065699 - D27.505.519.349.500
└─└─

Inducteurs du cytochrome P-450 CYP2E1

Cytochrome P-450 CYP2E1 Inducers D065700 - D27.505.519.349.600
└─└─

Inducteurs du cytochrome P-450 CYP3A

Cytochrome P-450 CYP3A Inducers D065701 - D27.505.519.349.700
└─└─

Antagonistes du récepteur de type A de l'endothéline

Endothelin A Receptor Antagonists D065130 - D27.505.519.364.500
└─└─

Antagonistes du récepteur de type B de l'endothéline

Endothelin B Receptor Antagonists D065131 - D27.505.519.364.750
└─└─

Activateurs de la Carbamoyl phosphate synthetase I

Carbamoyl Phosphate Synthetase I Activators D065097 - D27.505.519.374.099
└─└─

Activateurs de la GTPase

GTP Phosphohydrolase Activators D020549 - D27.505.519.374.200
└─└─

Inhibiteurs des protéines activatrices de la 5-lipoxygénase

5-Lipoxygenase-Activating Protein Inhibitors D058946 - D27.505.519.389.086
└─└─

Inhibiteurs de l'acétaldéhyde déshydrogénase

Acetaldehyde Dehydrogenase Inhibitors D065086 - D27.505.519.389.089
└─└─

Inhibiteurs de l'adénosine désaminase

Adenosine Deaminase Inhibitors D058892 - D27.505.519.389.092
└─└─

Inhibiteurs des adénylate cyclases

Adenylyl Cyclase Inhibitors D000067956 - D27.505.519.389.108
└─└─

Inhibiteurs de la calcineurine

Calcineurin Inhibitors D065095 - D27.505.519.389.174
└─└─

Inhibiteurs de l'anhydrase carbonique

Carbonic Anhydrase Inhibitors D002257 - D27.505.519.389.200
└─└─

Inhibiteurs et modulateurs de la gamma-secrétase

Gamma Secretase Inhibitors and Modulators D000091062 - D27.505.519.389.315
└─└─

Inhibiteurs des enzymes du cytochrome P-450

Cytochrome P-450 Enzyme Inhibitors D065607 - D27.505.519.389.335
└─└─

Antifoliques

Folic Acid Antagonists D005493 - D27.505.519.389.350
└─└─

Inhibiteurs de désacétylase d'histone

Histone Deacetylase Inhibitors D056572 - D27.505.519.389.360
└─└─

Inhibiteurs de l'intégrase

Integrase Inhibitors D019429 - D27.505.519.389.375
└─└─

Inhibiteurs de la lipoxygénase

Lipoxygenase Inhibitors D016859 - D27.505.519.389.480
└─└─

Inhibiteurs de la monoamine oxydase

Monoamine Oxidase Inhibitors D008996 - D27.505.519.389.616
└─└─

Inhibiteurs de la synthèse d'acide nucléique

Nucleic Acid Synthesis Inhibitors D019384 - D27.505.519.389.675
└─└─

Inhibiteurs de l'ornithine décarboxylase

Ornithine Decarboxylase Inhibitors D065108 - D27.505.519.389.705
└─└─

Inhibiteurs de la phosphodiestérase

Phosphodiesterase Inhibitors D010726 - D27.505.519.389.735
└─└─

Inhibiteurs des phosphoinositide-3 kinases

Phosphoinositide-3 Kinase Inhibitors D000081082 - D27.505.519.389.736
└─└─

Inhibiteurs de la phospholipase A2

Phospholipase A2 Inhibitors D064801 - D27.505.519.389.737
└─└─

Inhibiteurs de prolyle hydroxylases

Prolyl-Hydroxylase Inhibitors D064800 - D27.505.519.389.740
└─└─

Inhibiteurs de protéases

Protease Inhibitors D011480 - D27.505.519.389.745
└─└─

Inhibiteurs de protéines kinases

Protein Kinase Inhibitors D047428 - D27.505.519.389.755
└─└─

Inhibiteurs de la synthèse protéique

Protein Synthesis Inhibitors D011500 - D27.505.519.389.760
└─└─

Inhibiteurs de la pompe à protons

Proton Pump Inhibitors D054328 - D27.505.519.389.848
└─└─

Agents découplants

Uncoupling Agents D014475 - D27.505.519.389.936
└─└─

Agonistes de canaux chlorure

Chloride Channel Agonists D065101 - D27.505.519.562.311
└─└─

Agonistes de canaux sodiques

Sodium Channel Agonists D062687 - D27.505.519.562.625
└─└─

Mitogènes

Mitogens D008934 - D27.505.519.593.624
└─└─

Gazotransmetteurs

Gasotransmitters D064426 - D27.505.519.625.270
└─└─└─

Inhibiteurs de la synthèse d'acides gras

Fatty Acid Synthesis Inhibitors D054872 - D27.505.519.186.071.401
└─└─└─

Inhibiteurs du cytochrome P-450 CYP1A2

Cytochrome P-450 CYP1A2 Inhibitors D065609 - D27.505.519.389.335.120
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2B6

Cytochrome P-450 CYP2B6 Inhibitors D065686 - D27.505.519.389.335.260
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2C8

Cytochrome P-450 CYP2C8 Inhibitors D065687 - D27.505.519.389.335.308
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2C19

Cytochrome P-450 CYP2C19 Inhibitors D065689 - D27.505.519.389.335.319
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2C9

Cytochrome P-450 CYP2C9 Inhibitors D065688 - D27.505.519.389.335.329
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2D6

Cytochrome P-450 CYP2D6 Inhibitors D065690 - D27.505.519.389.335.368
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2E1

Cytochrome P-450 CYP2E1 Inhibitors D065691 - D27.505.519.389.335.421
└─└─└─

Inhibiteurs du cytochrome P-450 CYP3A

Cytochrome P-450 CYP3A Inhibitors D065692 - D27.505.519.389.335.503
└─└─└─

Inhibiteurs de la phosphodiestérase-3

Phosphodiesterase 3 Inhibitors D058987 - D27.505.519.389.735.249
└─└─└─

Inhibiteurs de la phosphodiestérase-4

Phosphodiesterase 4 Inhibitors D058988 - D27.505.519.389.735.374
└─└─└─

Inhibiteurs de la phosphodiestérase-5

Phosphodiesterase 5 Inhibitors D058986 - D27.505.519.389.735.500
└─└─└─

Inhibiteurs de l'enzyme de conversion de l'angiotensine

Angiotensin-Converting Enzyme Inhibitors D000806 - D27.505.519.389.745.085
└─└─└─

Inhibiteurs de la cystéine protéinase

Cysteine Proteinase Inhibitors D015853 - D27.505.519.389.745.325
└─└─└─

Inhibiteurs de métalloprotéinases matricielles

Matrix Metalloproteinase Inhibitors D061965 - D27.505.519.389.745.610
└─└─└─

Inhibiteurs du protéasome

Proteasome Inhibitors D061988 - D27.505.519.389.745.705
└─└─└─

Inhibiteurs de la rénine

Renin Inhibitors D000092502 - D27.505.519.389.745.753
└─└─└─

Inhibiteurs de la sérine protéinase

Serine Proteinase Inhibitors D015842 - D27.505.519.389.745.800
└─└─└─

Inhibiteurs des Janus kinases

Janus Kinase Inhibitors D000075242 - D27.505.519.389.755.500
└─└─└─

Inhibiteurs de protéine-tyrosine kinase

Tyrosine Protein Kinase Inhibitors D000092004 - D27.505.519.389.755.875
└─└─└─

Agonistes de canaux sodiques épithéliaux

Epithelial Sodium Channel Agonists D062708 - D27.505.519.562.625.249
└─└─└─

Agonistes de canaux sodiques voltage-dépendants

Voltage-Gated Sodium Channel Agonists D061585 - D27.505.519.562.625.500
└─└─└─

Inhibiteurs de canaux ioniques sensibles à l'acidité

Acid Sensing Ion Channel Blockers D062646 - D27.505.519.562.750.100
└─└─└─

Modulateurs de la polymérisation de la tubuline

Tubulin Modulators D050257 - D27.505.519.593.249.500
└─└─└─└─

Inhibiteurs des vasopeptidases

Vasopeptidase Inhibitors D000075563 - D27.505.519.389.745.085.500
└─└─└─└─

Inhibiteurs des caspases

Caspase Inhibitors D061945 - D27.505.519.389.745.325.500
└─└─└─└─

Inhibiteurs de serine peptidase de type Kazal

Serine Peptidase Inhibitors, Kazal Type D000074162 - D27.505.519.389.745.800.562
└─└─└─└─

Serpines

Serpins D015843 - D27.505.519.389.745.800.675
└─└─└─└─

Inhibiteurs trypsiques

Trypsin Inhibitors D014361 - D27.505.519.389.745.800.900

Auteurs principaux

Javad Sharifi-Rad

2 publications dans cette catégorie

Affiliations :
  • Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Daniela Calina

2 publications dans cette catégorie

Affiliations :
  • Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Yi Li

2 publications dans cette catégorie

Affiliations :
  • The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.

Yan Wang

2 publications dans cette catégorie

Affiliations :
  • The Second Medical College, Binzhou Medical University, Yantai, Shandong, China.
  • Department of Otolaryngology and Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
  • Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai, Shandong, China.

Ibrahim Jantan

2 publications dans cette catégorie

Affiliations :
  • Institute of Systems Biology, Universiti Kebangsaan Malaysia, Selangor, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Juriyati Jalil

2 publications dans cette catégorie

Affiliations :
  • Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Syaratul Dalina Yusoff

2 publications dans cette catégorie

Affiliations :
  • Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Khairana Husain

2 publications dans cette catégorie

Affiliations :
  • Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Wei Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Traditional Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Lin Li

2 publications dans cette catégorie

Affiliations :
  • Institute of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.

Ying Huai

2 publications dans cette catégorie

Affiliations :
  • Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Wei Wang

2 publications dans cette catégorie

Affiliations :
  • Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Kai Dang

2 publications dans cette catégorie

Affiliations :
  • Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Solomon Habtemariam

1 publication dans cette catégorie

Affiliations :
  • Pharmacognosy Research & Herbal Analysis Services UK, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, UK.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Senem Kamiloglu

1 publication dans cette catégorie

Affiliations :
  • Science and Technology Application and Research Center (BITAUM), Bursa Uludag University, Bursa, Turkey.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Balakyz Yeskaliyeva

1 publication dans cette catégorie

Affiliations :
  • Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Ahmet Beyatli

1 publication dans cette catégorie

Affiliations :
  • Department of Medicinal and Aromatic Plants, University of Health Sciences, Istanbul, Turkey.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Mary Angelia Alfred

1 publication dans cette catégorie

Affiliations :
  • Department of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Bahare Salehi

1 publication dans cette catégorie

Affiliations :
  • Medical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Anca Oana Docea

1 publication dans cette catégorie

Affiliations :
  • Department of Toxicology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Sources (684 au total)

Engineering a Bifunctional Fusion Purine/Pyrimidine Nucleoside Phosphorylase for the Production of Nucleoside Analogs.

Nucleoside phosphorylases (NPs) are pivotal enzymes in the salvage pathway, catalyzing the reversible phosphorolysis of nucleosides to produce nucleobases and α-D-ribose 1-phosphate. Due to their effi...